Jin Hee Sohn

Jin Hee Sohn

Auto-generated profile, based on publicly available information

Jin Hee Sohn

Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Cancer Research and Treatment
Verified
Journal Article
Open access
PDF file
MCMee-Yon Cho
Mee-Yon Cho
JKJoon Mee Kim
Joon Mee Kim
JSJin Hee Sohn
Jin Hee Sohn
MKMi-Jung Kim
Mi-Jung Kim
KKKyoung-Mee Kim
Kyoung-Mee Kim
SCSei Jin Chang
Sei Jin Chang
As a result of various independently proposed nomenclatures and classifications, there is confusion in the diagnosis and prediction of biological behavior of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). A comprehensive nationwide study is needed in order to understand the biological characteristics of GEP-NETs in Korea. We collected 4,951 pathology reports from 29 hospitals in Korea between 2000 and 2009. Kaplan-Meier survival analysis was used to determine the prognostic significance of clinicopathological parameters. Although the GEP-NET is a relatively rare tumor in Korea, its incidence has increased during the last decade, with the most significant increase found in the rectum. The 10-year survival rate for well-differentiated endocrine tumor was 92.89%, in contrast to 85.74% in well differentiated neuroendocrine carcinoma and 34.59% in poorly differentiated neuroendocrine carcinoma. Disease related death was most common in the biliary tract (62.2%) and very rare in the rectum (5.2%). In Kaplan-Meier survival analysis, tumor location, histological classification, extent, size, mitosis, Ki-67 labeling index, synaptophysin expression, lymphovascular invasion, perineural invasion, and lymph node metastasis showed prognostic significance (p<0.05), however, chromogranin expression did not (p=0.148). The 2000 and 2010 World Health Organization (WHO) classification proposals were useful for prediction of the prognosis of GEP-NET. The incidence of GEP-NET in Korea has shown a remarkable increase during the last decade, however, the distribution of tumors in the digestive system differs from that of western reports. Assessment of pathological parameters, including immunostaining, is crucial in understanding biological behavior of the tumor as well as predicting prognosis of patients with GEP-NET.

1 January 2010 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
MCMee-Yon Cho
Mee-Yon Cho
JSJin Hee Sohn
Jin Hee Sohn
JKJoon Mee Kim
Joon Mee Kim
KKKyoung-Mee Kim
Kyoung-Mee Kim
YPYoung Su Park
Young Su Park
SCSei Jin Chang
Sei Jin Chang
Cho MY, et al. J Korean Med Sci. 2010 Jun;25(6):853-862. https://doi.org/10.3346/jkms.2010.25.6.853

1 July 2016 in Human Pathology
Verified
Journal Article
Closed access
JPJung-Soo Pyo
Jung-Soo Pyo
JSJin Hee Sohn
Jin Hee Sohn
GKGuhyun Kang
Guhyun Kang

15 January 2020 in Journal of Pathology and Translational Medicine
Verified
Journal Article
Open access
PDF file
BKBaek-Hui Kim
Baek-Hui Kim
JKJoon Mee Kim
Joon Mee Kim
Gyeong-Hoon KangGyeong-Hoon Kang
Gyeong-Hoon Kang
HCHee Jin Chang
Hee Jin Chang
DKDong Wook Kang
Dong Wook Kang
YKYoun Wha Kim
Youn Wha Kim
The first edition of the 'Standardized Pathology Report for Colorectal Cancer,' which was developed by the Gastrointestinal Pathology Study Group (GIP) of the Korean Society of Pathologists, was published 13 years ago. Meanwhile, there have been many changes in the pathologic diagnosis of colorectal cancer (CRC), pathologic findings included in the pathology report, and immunohistochemical and molecular pathology required for the diagnosis and treatment of colorectal cancer. In order to reflect these changes, we (GIP) decided to make the second edition of the report. The purpose of this standardized pathology report is to provide a practical protocol for Korean pathologists, which could help diagnose and treat CRC patients. This report consists of "standard data elements" and "conditional data elements." Basic pathologic findings and parts necessary for prognostication of CRC patients are classified as "standard data elements," while other prognostic factors and factors related to adjuvant therapy are classified as "conditional data elements" so that each institution could select the contents according to the characteristics of the institution. The Korean version is also provided separately so that Korean pathologists can easily understand and use this report. We hope that this report will be helpful in the daily practice of CRC diagnosis.

1 April 2016 in The International Journal of Biological Markers
Verified
Journal Article
Closed access
JPJung-Soo Pyo
Jung-Soo Pyo
GKGuhyun Kang
Guhyun Kang
JSJin Hee Sohn
Jin Hee Sohn
Purpose: The aim of this study was to investigate the prognostic relevance of the Ki-67 labeling index (LI) in gastrointestinal stromal tumor (GIST) through a systematic review, meta-analysis and diagnostic test accuracy review. Method: The study included 1,967 GIST cases from 24 eligible studies. We investigated the correlation between high Ki-67 LI and survival and the proper criteria for high Ki-67 LI. In addition, a diagnostic test accuracy review was conducted to evaluate the predictive role of high Ki-67 LI for higher risk of tumor recurrence. Results: A high Ki-67 LI was significantly correlated with worse disease-free survival (DFS) (hazard ratio [HR] 3.658, 95% confidence interval [CI] 2.687-4.979, p<0.001) and overall survival (OS) (HR 3.730, 95% CI 2.819-4.936, p4% for high Ki-67 LI had a higher HR than the subgroup with a ≤4% cutoff. In the diagnostic test accuracy review, a high Ki-67 LI was significantly correlated with higher risk of tumor recurrence (pooled sensitivity = 0.44, pooled specificity = 0.87, area under the curve on the summary receiver operating characteristic curve = 0.656). Conclusions: Our results showed that a high Ki-67 LI was significantly correlated with worse prognosis and higher risk of tumor recurrence in GIST. Further prospective studies of the prognostic role of Ki-67 LI are necessary prior to application in clinical practice.

29 May 2013 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
JPJung‐Soo Pyo
Jung‐Soo Pyo
GKGuhyun Kang
Guhyun Kang
DKDong‐Hoon Kim
Dong‐Hoon Kim
CPChanheun Park
Chanheun Park
JKJoo Heon Kim
Joo Heon Kim
JSJin Hee Sohn
Jin Hee Sohn